The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Mohammed Aejaz Habeeb & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 2.9 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Mohammed Aejaz Habeeb, promoter of Samsrita Labs Ltd, along with Persons Acting in Concert (PACs), sold 7,38,000 equity shares (3.24% of total shareholding) via off-market transfer on 12-11-2025. His individual stake reduced from 14,79,124 shares (6.5%) to 7,41,124 shares (3.26%). The combined promoter and PAC group holding fell from 31.41% to 28.17% of the company. The buyer is not specified in the disclosure. The company's total equity share capital remains unchanged at Rs. 22,74,97,100 (2,27,49,710 shares of Rs. 10 each).
This is a notable promoter exit of over 3% via off-market route, which may be viewed negatively by retail investors as it signals reduced promoter skin-in-the-game. However, the remaining promoter group still holds a substantial 28.17%, and the off-market nature suggests a negotiated transfer rather than open-market pressure selling.